Conestoga Capital Advisors, LLC - BALCHEM CORP ownership

BALCHEM CORP's ticker is BCPC and the CUSIP is 057665200. A total of 238 filers reported holding BALCHEM CORP in Q4 2019. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.

Quarter-by-quarter ownership
Conestoga Capital Advisors, LLC ownership history of BALCHEM CORP
ValueSharesWeighting
Q3 2023$133,507,648
-6.1%
1,076,327
+2.0%
2.29%
+1.6%
Q2 2023$142,187,124
+7.1%
1,054,722
+0.5%
2.26%
+1.5%
Q1 2023$132,733,978
+4.5%
1,049,446
+0.9%
2.22%
-6.5%
Q4 2022$127,064,980
+1.1%
1,040,578
+0.7%
2.38%
-3.3%
Q3 2022$125,655,000
-3.9%
1,033,516
+2.6%
2.46%
+3.4%
Q2 2022$130,694,000
-5.5%
1,007,353
-0.4%
2.38%
+14.0%
Q1 2022$138,255,000
-18.1%
1,011,373
+1.1%
2.08%
-5.0%
Q4 2021$168,719,000
+16.6%
1,000,708
+0.4%
2.20%
+9.7%
Q3 2021$144,642,000
+16.5%
997,051
+5.4%
2.00%
+11.6%
Q2 2021$124,151,000
+4.1%
945,841
-0.6%
1.79%
-0.3%
Q1 2021$119,305,000
+10.3%
951,316
+1.3%
1.80%
+4.2%
Q4 2020$108,207,000
+19.0%
939,134
+0.8%
1.72%
-6.0%
Q3 2020$90,960,000
+7.9%
931,676
+4.8%
1.84%0.0%
Q2 2020$84,297,000
+0.8%
888,650
+4.9%
1.84%
-24.9%
Q1 2020$83,592,000
+1.5%
846,760
+4.5%
2.44%
+23.4%
Q4 2019$82,350,000
+1.3%
810,293
-1.1%
1.98%
-4.7%
Q3 2019$81,283,000
-1.2%
819,465
-0.4%
2.08%
+1.2%
Q2 2019$82,255,000
+10.5%
822,800
+2.6%
2.06%
-0.8%
Q1 2019$74,425,000
+19.4%
801,988
+0.8%
2.07%
+4.3%
Q4 2018$62,358,000
-25.8%
795,884
+6.2%
1.99%
-7.3%
Q3 2018$84,020,000
+31.5%
749,579
+15.1%
2.14%
+4.2%
Q2 2018$63,915,000
+29.3%
651,264
+7.7%
2.06%
+8.7%
Q1 2018$49,420,000
-1.2%
604,524
-2.6%
1.89%
-1.4%
Q4 2017$50,010,000
+15.2%
620,469
+16.2%
1.92%0.0%
Q3 2017$43,400,000
+56.0%
533,894
+49.1%
1.92%
+32.6%
Q2 2017$27,824,000
+4.2%
358,044
+10.5%
1.45%
-10.3%
Q1 2017$26,712,000
+8.5%
324,099
+10.5%
1.62%
-1.5%
Q4 2016$24,613,000
-15.8%
293,288
-22.2%
1.64%
-18.2%
Q3 2016$29,227,000
+33.2%
376,973
+2.5%
2.00%
+23.6%
Q2 2016$21,940,000
-18.0%
367,808
-14.8%
1.62%
-10.3%
Q1 2016$26,758,000
+4.5%
431,448
+2.5%
1.81%
-12.6%
Q4 2015$25,598,000
-21.8%
421,023
-21.8%
2.07%
-21.1%
Q3 2015$32,717,000
+6.3%
538,375
-2.6%
2.62%
+22.7%
Q2 2015$30,786,000
-0.8%
552,520
-1.4%
2.14%
+0.6%
Q1 2015$31,043,000
-19.6%
560,540
-3.3%
2.12%
-20.9%
Q4 2014$38,625,000
+10.1%
579,605
-6.6%
2.69%
+4.8%
Q3 2014$35,093,000
+10.3%
620,348
+4.5%
2.56%
+20.1%
Q2 2014$31,802,000
-15.0%
593,768
-17.3%
2.13%
-9.8%
Q1 2014$37,427,000
+3.6%
718,091
+16.7%
2.37%
-2.5%
Q4 2013$36,129,000
+28.8%
615,486
+13.6%
2.43%
+1.0%
Q3 2013$28,050,000
+18.1%
542,026
+2.1%
2.40%
-2.0%
Q2 2013$23,747,000
+10.6%
530,651
+8.6%
2.45%
+7.6%
Q1 2013$21,467,000488,5512.28%
Other shareholders
BALCHEM CORP shareholders Q4 2019
NameSharesValueWeighting ↓
SANTA MONICA PARTNERS LP 318,131$43,489,00030.49%
Conestoga Capital Advisors, LLC 1,011,373$138,255,0002.08%
GENEVA CAPITAL MANAGEMENT LLC 648,244$88,614,0001.71%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 65,418$8,943,0001.46%
Cutter & CO Brokerage, Inc. 31,950$4,368,0001.30%
Tributary Capital Management, LLC 113,315$15,490,0001.22%
MOODY ALDRICH PARTNERS LLC 55,362$7,568,0001.06%
WASATCH ADVISORS LP 1,499,158$204,935,0001.01%
ICW Investment Advisors LLC 10,941$1,496,0000.86%
CARDEROCK CAPITAL MANAGEMENT INC 19,428$2,656,0000.86%
View complete list of BALCHEM CORP shareholders